Agent-based computational models to explore diffusion of medical innovations among cardiologists

https://doi.org/10.1016/j.ijmedinf.2018.02.008Get rights and content

Highlights

  • Diffusion of innovations is often driven by social contagion or imitation.

  • Agent-based models (ABM) are useful to explore diffusion of medical innovations.

  • ABM demonstrates the interaction of variables associated to innovation spreading.

  • ABM provides a semiquantitative insight on doctors’ emergent collective behavior.

Abstract

Background

Diffusion of medical innovations among physicians rests on a set of theoretical assumptions, including learning and decision-making under uncertainty, social-normative pressures, medical expert knowledge, competitive concerns, network performance effects, professional autonomy or individualism and scientific evidence.

Objectives

The aim of this study was to develop and test four real data-based, agent-based computational models (ABM) to qualitatively and quantitatively explore the factors associated with diffusion and application of innovations among cardiologists.

Methods

Four ABM were developed to study diffusion and application of medical innovations among cardiologists, considering physicians’ network connections, leaders’ opinions, “adopters’ categories”, physicians’ autonomy, scientific evidence, patients’ pressure, affordability for the end-user population, and promotion from companies.

Results

Simulations demonstrated that social imitation among local cardiologists was sufficient for innovation diffusion, as long as opinion leaders did not act as detractors of the innovation. Even in the absence of full scientific evidence to support innovation, up to one-fifth of cardiologists could accept it when local leaders acted as promoters. Patients’ pressure showed a large effect size (Cohen's d > 1.2) on the proportion of cardiologists applying an innovation. Two qualitative patterns (speckled and granular) appeared associated to traditional Gompertz and sigmoid cumulative distributions.

Conclusions

These computational models provided a semiquantitative insight on the emergent collective behavior of a physician population facing the acceptance or refusal of medical innovations. Inclusion in the models of factors related to patients’ pressure and accesibility to medical coverage revealed the contrast between accepting and effectively adopting a new product or technology for population health care.

Introduction

It is commonly accepted that diffusion of innovations is often driven by social contagion or imitation [1]. Specifically, diffusion of medical innovations among physicians rests on a set of theoretical assumptions, including learning and decision-making under uncertainty, social-normative pressures, medical expert knowledge, competitive concerns, network performance effects, professional autonomy or individualism, and scientific evidence [2]. The process of propagation and adoption of medical innovations is not only relevant for marketing research, but also because differences in the performance of medical care may be due to variation in the introduction, diffusion and acceptance of new practices [[3], [4], [5], [6]].

Mathematical representation on the basis of Bass [[4], [5], [6], [7]] or Gamma-Shifted Gompertz [1] models and local interaction models for social networks [8] were traditionally used to explore diffusion of innovations. Low-dimensional differential equations, aggregate regression analysis, and game theory methods are appropriate for some explanatory purposes; however, agent-based computational modeling (ABM) is the main tool in the analysis of spatially distributed systems with heterogeneous autonomous actors connected in social networks, particularly, when decision-making relies on restrained information and limited individual rationality or computing capacity [9]. In ABM, a system is designed as a collection of independent decision-making entities called agents, where each agent individually assesses its situation and makes decisions on the basis of a set of rules. An advantage of ABM is that it computes repetitive competitive interactions between agents to explore population dynamics out of reach of traditional differential equation modeling [10]. As a tool for real-world empirical research, ABM can generate stable macroscopic patterns arising from local interaction of agents, known as emergent phenomena [9]. Agent-based computational modeling applies to cases where people are influenced by their social context, i.e. what others around them do; therefore, it can be used to model diffusion of ideas, products or innovations on social networks. Previously, only a few studies used the ABM approach to model diffusion of medical innovations. These studies provided support to the importance of social networks and external influences in the diffusion process [11], the effect of the interaction between patients and physicians to adopt a new technology [12] and the value of opinion leadership on adopting new evidence [13].

The aim of this study was to develop and test four real data-based ABM to qualitatively and quantitatively explore the factors associated with diffusion and application of innovations among cardiologists.

Section snippets

Material and methods

Four ABM were developed to study diffusion and/or effective use of medical innovations among cardiologists with real-world data. In this application of ABM to medical sociology, agents represented physicians, and agent relationships represented the processes of social interaction. For modeling purposes physicians were generally assumed to be the decision-makers in the system after local regulatory approval, peer opinion leaders were considered to be polymorphic (influential across a wide range

Statistical analysis

Diffusion of a hypothetical innovation was qualitatively represented by means of two-dimensional images showing the different patterns of innovation spreading. Quantitative discrete data were also obtained from repeated simulations on different scenarios, and treated as discrete choice analysis. Both ABM included stochastic elements to model the range of outcomes for agent behaviors and interactions which were not known with certainty. Parameter values used in stochastic simulations included

Results

Fig. 1 shows a set of simulation images demonstrating the influence of one top local leader’s opinion on the diffusion of an innovation among cardiologists through time, according to Rogers’ diffusion of innovations theory-based model. After 100 simulations, diffusion of the hypothetical innovation reached 84.0% (SD3.1) of cardiologists after 20 units of time (iterations), when the top local leader’s opinion promoted the innovation. For a neutral opinion of the leader, the innovation diffusion

Discussion

In this study, ABM were capable of representing the interaction of multiple variables associated to medical innovation diffusion among cardiologists in a community. Behaviors emerging from network connections, leaders’ opinions, “adopters’ categories”, physicians’ autonomy, scientific evidence, patients’ pressure, affordability, and marketing information from pharmaceutical companies provided a set of qualitative patterns and quantitative data useful to understand the complex dynamics of the

Conclusions

These models provided a semi quantitative insight on the emergent collective behavior of a physician population facing the acceptance or refusal of medical innovations. The interdependent relationship between social contagion according to “adopters’ categories”, the influence of local leaders’ opinions on the physicians’ network, and the significance of scientific evidence and doctors’ autonomous decision revealed a set of helpful qualitative propagation patterns and quantitative data to

Funding

None.

Authors’ contributions

R.A. Borracci: conception and design of the study, acquisition, analysis and interpretation of data; drafting the manuscript; and final approval of the submitted version.

M.A. Giorgi: design of the study, acquisition, analysis and interpretation of data; critically revising of the article critically for important intellectual content; and final approval of the submitted version

Statements on conflicts of interest

R.A. Borracci has no relationship with the industry and has no conflicts of interest regarding this paper.

M.A. Giorgi received research grants from Bristol Myers Squibb, Pfizer, and Novartis, and consulting fees from Bristol Myers Squibb, Pfizer, Novartis, Merck Serono, and Danone. All these grants were not related to the current study.

Summary table

What was already known on the topic

The process of propagation and adoption of medical innovations is not only relevant for marketing research, but

References (35)

  • H. Verdoux et al.

    Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care

    Schizophr. Res.

    (2005)
  • E. West et al.

    Hierarchies and cliques in the social networks of health care professionals: implications for the design of dissemination strategies

    Soc. Sci. Med.

    (1999)
  • C. Van den Bulte et al.

    Social contagion and income heterogeneity in new product diffusion: a meta-analytic test

    Market. Sci

    (2004)
  • C. Van den Bulte et al.

    Medical innovation revisited: social-contagion versus marketing effort

    Am. J. Sociol.

    (2001)
  • R. Westerling et al.

    The timing of introduction of pharmaceutical innovations in seven European countries

    J. Eval. Clin. Pract.

    (2014)
  • A.G. Dunn et al.

    Nation-scale adoption of new medicines by doctors: an application of the bass diffusion model

    BMC Health Serv. Res.

    (2012)
  • S.D. Scott et al.

    Factors influencing the adoption of an innovation: an examination of the uptake of the Canadian Heart Health Kit (HHK)

    Implement. Sci.

    (2008)
  • M.R. Greenberg

    The diffusion of public health innovations

    Am. J. Public Health

    (2006)
  • F.M. Bass

    A new product growth for model consumer durables

    Manag. Sci.

    (1969)
  • G.E. Kreinder et al.

    Rapid innovation diffusion in social networks

    Proc. Natl. Acad. Sci. U.S.A.

    (2014)
  • J.M. Epstein

    Agent-based computational models and generative social science

    Complexity

    (1999)
  • E. Bonabeau

    Agent-based modeling: methods and techniques for simulating human systems

    Proc. Natl. Acad. Sci. U.S.A.

    (2002)
  • N.N. Ratna et al.

    Diffusion and social networks: revisiting medical innovation with agents

  • J.T. Verella et al.

    Toward an agent-based patient-physician model for the adoption of continuous glucose monitoring technology

    J. Diabetes Sci. Technol.

    (2009)
  • C.A. Anderson et al.

    Development and verification of an agent-based model of opinion leadership

    Implement. Sci.

    (2014)
  • C.M. Macal et al.

    Tutorial on agent-based modeling and simulation. Part 2: how to model with agents

    Proceedings of the 2006 Winter Simulation Conference

    (2006)
  • B. Ryan et al.

    The diffusion of hybrid seed corn in two Iowa communities

    Rural Soc.

    (1943)
  • Cited by (0)

    View full text